Sector Chart Atossa Therapeutics, Inc.

Stocks

ATOS

US04962H7044

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 28/09/2026 BST			5-day change	1st Jan Change
1.960 ^USD	+3.16%		-12.89%	-77.85%

09-21	Atossa Therapeutics, Inc.(NasdaqCM:ATOS) dropped from S&P Global BMI Index	CI
08-07	Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ATOSSA THERAPEUTICS, INC.	19.56M	-	-	-	-	-
LONZA GROUP AG	49.06B
IQVIA HOLDINGS INC.	44.6B
REVOLUTION MEDICINES, INC.	43.24B	-	-	-	-	-
BEONE MEDICINES AG	41.73B
CELLTRION, INC.	29.93B